Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
IEEE Rev Biomed Eng ; 14: 48-70, 2021.
Article in English | MEDLINE | ID: covidwho-1501336

ABSTRACT

Coronavirus disease 2019 (COVID-19) has emerged as a pandemic with serious clinical manifestations including death. A pandemic at the large-scale like COVID-19 places extraordinary demands on the world's health systems, dramatically devastates vulnerable populations, and critically threatens the global communities in an unprecedented way. While tremendous efforts at the frontline are placed on detecting the virus, providing treatments and developing vaccines, it is also critically important to examine the technologies and systems for tackling disease emergence, arresting its spread and especially the strategy for diseases prevention. The objective of this article is to review enabling technologies and systems with various application scenarios for handling the COVID-19 crisis. The article will focus specifically on 1) wearable devices suitable for monitoring the populations at risk and those in quarantine, both for evaluating the health status of caregivers and management personnel, and for facilitating triage processes for admission to hospitals; 2) unobtrusive sensing systems for detecting the disease and for monitoring patients with relatively mild symptoms whose clinical situation could suddenly worsen in improvised hospitals; and 3) telehealth technologies for the remote monitoring and diagnosis of COVID-19 and related diseases. Finally, further challenges and opportunities for future directions of development are highlighted.


Subject(s)
COVID-19/diagnosis , Pandemics/prevention & control , Technology/methods , Telemedicine/methods , COVID-19/virology , Delivery of Health Care/methods , Humans , SARS-CoV-2/pathogenicity , Wearable Electronic Devices
3.
IEEE Rev Biomed Eng ; 14: 16-29, 2021.
Article in English | MEDLINE | ID: covidwho-1501334

ABSTRACT

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading rapidly around the world, resulting in a massive death toll. Lung infection or pneumonia is the common complication of COVID-19, and imaging techniques, especially computed tomography (CT), have played an important role in diagnosis and treatment assessment of the disease. Herein, we review the imaging characteristics and computing models that have been applied for the management of COVID-19. CT, positron emission tomography - CT (PET/CT), lung ultrasound, and magnetic resonance imaging (MRI) have been used for detection, treatment, and follow-up. The quantitative analysis of imaging data using artificial intelligence (AI) is also explored. Our findings indicate that typical imaging characteristics and their changes can play crucial roles in the detection and management of COVID-19. In addition, AI or other quantitative image analysis methods are urgently needed to maximize the value of imaging in the management of COVID-19.


Subject(s)
COVID-19/diagnosis , Artificial Intelligence , COVID-19/diagnostic imaging , Humans , Lung/diagnostic imaging , Lung/virology , Positron Emission Tomography Computed Tomography/methods , SARS-CoV-2/pathogenicity , Tomography, X-Ray Computed/methods , Ultrasonography/methods
4.
Electronics ; 10(17):2151, 2021.
Article in English | ProQuest Central | ID: covidwho-1403560

ABSTRACT

Social networks are known for their decentralization and democracy. Each individual has a chance to participate and influence any discussion. Even with all the freedom, people’s behavior falls under patterns that are observed in numerous situations. In this paper, we propose a methodology that defines and searches for common communication patterns in topical networks on Twitter. We analyze clusters according to four traits: number of nodes the cluster has, their degree and betweenness centrality values, number of node types, and whether the cluster is open or closed. We find that cluster structures can be defined as (a) fixed, meaning that they are repeated across datasets/topics following uniform rules, or (b) variable if they follow an underlying rule regardless of their size. This approach allows us to classify 90% of all conversation clusters, with the number varying by topic. An increase in cluster size often results in difficulties finding topological shape rules;however, these types of clusters tend to exhibit rules regarding their node relationships in the form of centralization. Most individuals do not enter large-scale discussions on Twitter, meaning that the simplicity of communication clusters implies repetition. In general, power laws apply for the influencer connection distribution (degree centrality) even in topical networks.

5.
BMC Med Imaging ; 21(1): 57, 2021 03 23.
Article in English | MEDLINE | ID: covidwho-1148211

ABSTRACT

BACKGROUND: Spatial and temporal lung infection distributions of coronavirus disease 2019 (COVID-19) and their changes could reveal important patterns to better understand the disease and its time course. This paper presents a pipeline to analyze statistically these patterns by automatically segmenting the infection regions and registering them onto a common template. METHODS: A VB-Net is designed to automatically segment infection regions in CT images. After training and validating the model, we segmented all the CT images in the study. The segmentation results are then warped onto a pre-defined template CT image using deformable registration based on lung fields. Then, the spatial distributions of infection regions and those during the course of the disease are calculated at the voxel level. Visualization and quantitative comparison can be performed between different groups. We compared the distribution maps between COVID-19 and community acquired pneumonia (CAP), between severe and critical COVID-19, and across the time course of the disease. RESULTS: For the performance of infection segmentation, comparing the segmentation results with manually annotated ground-truth, the average Dice is 91.6% ± 10.0%, which is close to the inter-rater difference between two radiologists (the Dice is 96.1% ± 3.5%). The distribution map of infection regions shows that high probability regions are in the peripheral subpleural (up to 35.1% in probability). COVID-19 GGO lesions are more widely spread than consolidations, and the latter are located more peripherally. Onset images of severe COVID-19 (inpatients) show similar lesion distributions but with smaller areas of significant difference in the right lower lobe compared to critical COVID-19 (intensive care unit patients). About the disease course, critical COVID-19 patients showed four subsequent patterns (progression, absorption, enlargement, and further absorption) in our collected dataset, with remarkable concurrent HU patterns for GGO and consolidations. CONCLUSIONS: By segmenting the infection regions with a VB-Net and registering all the CT images and the segmentation results onto a template, spatial distribution patterns of infections can be computed automatically. The algorithm provides an effective tool to visualize and quantify the spatial patterns of lung infection diseases and their changes during the disease course. Our results demonstrate different patterns between COVID-19 and CAP, between severe and critical COVID-19, as well as four subsequent disease course patterns of the severe COVID-19 patients studied, with remarkable concurrent HU patterns for GGO and consolidations.


Subject(s)
COVID-19/diagnostic imaging , Community-Acquired Infections/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Algorithms , Disease Progression , Humans , Pneumonia/diagnostic imaging , Tomography, X-Ray Computed/methods
6.
Med Phys ; 48(4): 1633-1645, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-938495

ABSTRACT

OBJECTIVE: Computed tomography (CT) provides rich diagnosis and severity information of COVID-19 in clinical practice. However, there is no computerized tool to automatically delineate COVID-19 infection regions in chest CT scans for quantitative assessment in advanced applications such as severity prediction. The aim of this study was to develop a deep learning (DL)-based method for automatic segmentation and quantification of infection regions as well as the entire lungs from chest CT scans. METHODS: The DL-based segmentation method employs the "VB-Net" neural network to segment COVID-19 infection regions in CT scans. The developed DL-based segmentation system is trained by CT scans from 249 COVID-19 patients, and further validated by CT scans from other 300 COVID-19 patients. To accelerate the manual delineation of CT scans for training, a human-involved-model-iterations (HIMI) strategy is also adopted to assist radiologists to refine automatic annotation of each training case. To evaluate the performance of the DL-based segmentation system, three metrics, that is, Dice similarity coefficient, the differences of volume, and percentage of infection (POI), are calculated between automatic and manual segmentations on the validation set. Then, a clinical study on severity prediction is reported based on the quantitative infection assessment. RESULTS: The proposed DL-based segmentation system yielded Dice similarity coefficients of 91.6% ± 10.0% between automatic and manual segmentations, and a mean POI estimation error of 0.3% for the whole lung on the validation dataset. Moreover, compared with the cases with fully manual delineation that often takes hours, the proposed HIMI training strategy can dramatically reduce the delineation time to 4 min after three iterations of model updating. Besides, the best accuracy of severity prediction was 73.4% ± 1.3% when the mass of infection (MOI) of multiple lung lobes and bronchopulmonary segments were used as features for severity prediction, indicating the potential clinical application of our quantification technique on severity prediction. CONCLUSIONS: A DL-based segmentation system has been developed to automatically segment and quantify infection regions in CT scans of COVID-19 patients. Quantitative evaluation indicated high accuracy in automatic infection delineation and severity prediction.


Subject(s)
COVID-19/diagnostic imaging , Deep Learning , Image Interpretation, Computer-Assisted , Lung/diagnostic imaging , Tomography, X-Ray Computed , Humans
7.
Heart ; 106(15): 1154-1159, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-155332

ABSTRACT

OBJECTIVE: We sought to explore the prevalence and immediate clinical implications of acute myocardial injury in a cohort of patients with COVID-19 in a region of China where medical resources are less stressed than in Wuhan (the epicentre of the pandemic). METHODS: We prospectively assessed the medical records, laboratory results, chest CT images and use of medication in a cohort of patients presenting to two designated covid-19 treatment centres in Sichuan, China. Outcomes of interest included death, admission to an intensive care unit (ICU), need for mechanical ventilation, treatment with vasoactive agents and classification of disease severity. Acute myocardial injury was defined by a value of high-sensitivity troponin T (hs-TnT) greater than the normal upper limit. RESULTS: A total of 101 cases were enrolled from January to 10 March 2020 (average age 49 years, IQR 34-62 years). Acute myocardial injury was present in 15.8% of patients, nearly half of whom had a hs-TnT value fivefold greater than the normal upper limit. Patients with acute myocardial injury were older, with a higher prevalence of pre-existing cardiovascular disease and more likely to require ICU admission (62.5% vs 24.7%, p=0.003), mechanical ventilation (43.5% vs 4.7%, p<0.001) and treatment with vasoactive agents (31.2% vs 0%, p<0.001). Log hs-TnT was associated with disease severity (OR 6.63, 95% CI 2.24 to 19.65), and all of the three deaths occurred in patients with acute myocardial injury. CONCLUSION: Acute myocardial injury is common in patients with COVID-19 and is associated with adverse prognosis.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Troponin T/blood , Adult , Age Factors , Angiotensin Receptor Antagonists/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Biomarkers/blood , C-Reactive Protein/analysis , COVID-19 , Cardiovascular Agents/therapeutic use , China/epidemiology , Cohort Studies , Glomerular Filtration Rate , Humans , Intensive Care Units/statistics & numerical data , Middle Aged , Natriuretic Peptide, Brain/blood , Pandemics , Peptide Fragments/blood , Prognosis , SARS-CoV-2 , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL